{"id":618158,"date":"2022-09-23T20:34:02","date_gmt":"2022-09-23T20:34:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=618158"},"modified":"2022-09-23T20:34:02","modified_gmt":"2022-09-23T20:34:02","slug":"plaque-psoriasis-market-is-projected-to-boost-at-a-moderate-growth-rate-by-20222032-evaluated-by-delveinsight-key-companies-meiji-soligenix-dermavant-sciences-lipidor-ab","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/plaque-psoriasis-market-is-projected-to-boost-at-a-moderate-growth-rate-by-20222032-evaluated-by-delveinsight-key-companies-meiji-soligenix-dermavant-sciences-lipidor-ab_618158.html","title":{"rendered":"Plaque Psoriasis Market is Projected to Boost at a Moderate Growth Rate by (2022-2032) &#8211; Evaluated by DelveInsight | Key Companies &#8211; Meiji, Soligenix, Dermavant Sciences, Lipidor AB"},"content":{"rendered":"<div style=\"float:right;  width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1663917422.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Plaque Psoriasis Market is Projected to Boost at a Moderate Growth Rate by (2022-2032) - Evaluated by DelveInsight | Key Companies - Meiji, Soligenix, Dermavant Sciences, Lipidor AB\" src=\"https:\/\/www.abnewswire.com\/uploads\/1663917422.jpeg\" alt=\"Plaque Psoriasis Market is Projected to Boost at a Moderate Growth Rate by (2022-2032) - Evaluated by DelveInsight | Key Companies - Meiji, Soligenix, Dermavant Sciences, Lipidor AB\" width=\"225\" height=\"225\" \/><\/a><\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">DelveInsight\u2019s \u201cPlaque Psoriasis Market Insights, Epidemiology, and Market Forecast-2032\u2033 report offers an in-depth understanding of the Plaque Psoriasis, historical and forecasted epidemiology as well as the Plaque Psoriasis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/div>\n<p style=\"text-align: justify;\">The <strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/plaque-psoriasis-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=gpr\">Plaque Psoriasis market<\/a><\/strong> is expected to surge due to the disease&#8217;s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Plaque Psoriasis pipeline products will significantly revolutionize the Plaque Psoriasis market dynamics.&nbsp;&nbsp;<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Plaque Psoriasis Overview<\/strong><\/p>\n<p style=\"text-align: justify;\">Psoriasis, a skin disorder, may cause itchiness and discomfort. Plaque psoriasis, the most common type, causes thick, scaly patches of skin. Plaque psoriasis also known as Psoriasis vulgaris is considered as an autoimmune disease. Plaque psoriasis depends on heredity and trigger response of the immune system.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Some of the key facts of the Plaque Psoriasis Market Report:&nbsp;<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>The Plaque Psoriasis market size is anticipated to grow with a significant <strong>CAGR<\/strong> during the study period <strong>(2019-2032)<\/strong>&nbsp;<\/li>\n<li>Psoriasis is a chronic, immune disease that affects the skin. It occurs when the immune system sendsout faulty signals that speed up the growth cycle of skin cells&nbsp;<\/li>\n<li>According to Wilson et al., About <strong>80<\/strong> to <strong>90<\/strong> percent of people living with psoriasis experienceplaque psoriasis (Psoriasis vulgaris)&nbsp;<\/li>\n<li>Psoriasis is prevalent worldwide with a global prevalence of<strong> 1%<\/strong> to<strong> 8%<\/strong>. It begins in childhood in approximately one-third of cases.&nbsp;<\/li>\n<li><strong>Key Plaque Psoriasis Companies:<\/strong> Meiji, Soligenix, Dermavant Sciences, Lipidor AB, and others<\/li>\n<li><strong>Key Plaque Psoriasis Therapies:<\/strong> SGX302, Tapinarof, AKP02, AKVANO, ME3183, and others&nbsp;<\/li>\n<li>The Plaque Psoriasis epidemiology based on gender analyzed that males are slightly more affected with Plaque Psoriasis as compared to females&nbsp;<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\">Get a Free sample for the <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/plaque-psoriasis-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=gpr\">Plaque Psoriasis Market Report<\/a>&nbsp;<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\">Key benefits of the Plaque Psoriasis Market report:<\/p>\n<ol style=\"text-align: justify;\" start=\"1\">\n<li>Plaque Psoriasis market report covers a descriptive overview and comprehensive insight of the Plaque Psoriasis Epidemiology and Plaque Psoriasis market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) &amp; Japan.)<\/li>\n<li>The Plaque Psoriasis market report provides insights on the current and emerging therapies.<\/li>\n<li>Plaque Psoriasis market report provides a global historical and forecasted market covering drug outreach in 7MM.<\/li>\n<li>The Plaque Psoriasis market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Plaque Psoriasis market.<\/li>\n<\/ol>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Discover more about therapies set to grab major Plaque Psoriasis market share @ <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/plaque-psoriasis-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=gpr\">Plaque Psoriasis market forecast<\/a>&nbsp;&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Plaque Psoriasis Epidemiology Segmentation:<\/strong><\/p>\n<p style=\"text-align: justify;\">The Plaque Psoriasis market report proffers epidemiological analysis for the study period 2019&ndash;2032 in the 7MM segmented into:<\/p>\n<ul style=\"text-align: justify;\">\n<li>Total Prevalence of Plaque Psoriasis<\/li>\n<li>Prevalent Cases of Plaque Psoriasis by severity<\/li>\n<li>Gender-specific Prevalence of Plaque Psoriasis<\/li>\n<li>Diagnosed Cases of Episodic and Chronic Plaque Psoriasis<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Plaque Psoriasis Market<\/strong> &nbsp;<\/p>\n<p style=\"text-align: justify;\">The dynamics of the Plaque Psoriasis market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as <strong>AKP02, AKVANO,<\/strong> and others during the forecasted period 2019-2032.&nbsp;<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Download the report to understand which factors are driving Plaque Psoriasis epidemiology trends @ <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/plaque-psoriasis-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=gpr\">Plaque Psoriasis Epidemiological Insights<\/a>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Plaque Psoriasis Therapies and Key Companies<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>SGX302: Soligenix<\/li>\n<li>Tapinarof: Dermavant Sciences<\/li>\n<li>AKP02\/AKVANO: Lipidor AB<\/li>\n<li>ME3183: Meiji<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Scope of the Plaque Psoriasis Market Report<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li><strong>Study Period: 2019&ndash;2032<\/strong><\/li>\n<li><strong>Coverage:<\/strong> 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]<\/li>\n<li><strong>Key Plaque Psoriasis Companies:<\/strong> Meiji, Soligenix, Dermavant Sciences, Lipidor AB, and others<\/li>\n<li><strong>Key Plaque Psoriasis Therapies:<\/strong> SGX302, Tapinarof, AKP02, AKVANO, ME3183, and others<\/li>\n<li><strong>Plaque Psoriasis Therapeutic Assessment:<\/strong> Plaque Psoriasis current marketed and Plaque Psoriasis emerging therapies<\/li>\n<li><strong>Plaque Psoriasis Market Dynamics:<\/strong> Plaque Psoriasis market drivers and Plaque Psoriasis market barriers&nbsp;<\/li>\n<li><strong>Competitive Intelligence Analysis:<\/strong> SWOT analysis, PESTLE analysis, Porter&rsquo;s five forces, BCG Matrix, Market entry strategies<\/li>\n<li><strong>Unmet Needs, KOL&rsquo;s views, Analyst&rsquo;s views, Plaque Psoriasis Market Access and Reimbursement&nbsp;<\/strong><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Table of Contents&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\">1. Plaque Psoriasis Market Report Introduction<\/p>\n<p style=\"text-align: justify;\">2. Executive Summary for Plaque Psoriasis<\/p>\n<p style=\"text-align: justify;\">3. SWOT analysis of Plaque Psoriasis<\/p>\n<p style=\"text-align: justify;\">4. Plaque Psoriasis Patient Share (%) Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">5. Plaque Psoriasis Market Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">6. Plaque Psoriasis Disease Background and Overview<\/p>\n<p style=\"text-align: justify;\">7. Plaque Psoriasis Epidemiology and Patient Population<\/p>\n<p style=\"text-align: justify;\">8. Country-Specific Patient Population of Plaque Psoriasis&nbsp;<\/p>\n<p style=\"text-align: justify;\">9. Plaque Psoriasis Current Treatment and Medical Practices<\/p>\n<p style=\"text-align: justify;\">10. Plaque Psoriasis Unmet Needs<\/p>\n<p style=\"text-align: justify;\">11. Plaque Psoriasis Emerging Therapies<\/p>\n<p style=\"text-align: justify;\">12. Plaque Psoriasis Market Outlook<\/p>\n<p style=\"text-align: justify;\">13. Country-Wise Plaque Psoriasis Market Analysis (2019&ndash;2032)<\/p>\n<p style=\"text-align: justify;\">14. Plaque Psoriasis Market Access and Reimbursement of Therapies<\/p>\n<p style=\"text-align: justify;\">15. Plaque Psoriasis Market Drivers<\/p>\n<p style=\"text-align: justify;\">16. Plaque Psoriasis Market Barriers<\/p>\n<p style=\"text-align: justify;\">17.&nbsp; Plaque Psoriasis Appendix<\/p>\n<p style=\"text-align: justify;\">18. Plaque Psoriasis Report Methodology<\/p>\n<p style=\"text-align: justify;\">19. DelveInsight Capabilities<\/p>\n<p style=\"text-align: justify;\">20. Disclaimer<\/p>\n<p style=\"text-align: justify;\">21. About DelveInsight<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>To know more about Plaque Psoriasis treatment, visit @ <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/plaque-psoriasis-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=gpr\">Plaque Psoriasis Medications<\/a><\/strong><\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_75707.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Gaurav Bora<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=plaque-psoriasis-market-is-projected-to-boost-at-a-moderate-growth-rate-by-20222032-evaluated-by-delveinsight-key-companies-meiji-soligenix-dermavant-sciences-lipidor-ab\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 9193216187<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Las Vegas<br \/><strong>State:<\/strong> Nevada<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=plaque-psoriasis-market-is-projected-to-boost-at-a-moderate-growth-rate-by-20222032-evaluated-by-delveinsight-key-companies-meiji-soligenix-dermavant-sciences-lipidor-ab\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>DelveInsight\u2019s \u201cPlaque Psoriasis Market Insights, Epidemiology, and Market Forecast-2032\u2033 report offers an in-depth understanding of the Plaque Psoriasis, historical and forecasted epidemiology as well as the Plaque Psoriasis market trends in the United States, EU5 (Germany, Spain, Italy, France, and &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/plaque-psoriasis-market-is-projected-to-boost-at-a-moderate-growth-rate-by-20222032-evaluated-by-delveinsight-key-companies-meiji-soligenix-dermavant-sciences-lipidor-ab_618158.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,417,406,423],"tags":[],"class_list":["post-618158","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Marketing-Sales","category-Pharmaceuticals-Biotech","category-Professional-Services"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/618158","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=618158"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/618158\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=618158"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=618158"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=618158"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}